$28.1M in CY2024 Part D spend244K claims · 69K beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Fesoterodine used for?
Fesoterodine fumarate extended-release tablets are indicated for the treatment of: Overactive bladder (OAB) in adults with symptoms of urge urinary incontinence, urgency, and frequency. ( 1.1 ) 1.1....
Is there a generic for Fesoterodine?
Yes. 14 ANDAs filed at FDA, 7 generic manufacturers currently shipping.
How much does my plan pay for Fesoterodine?
Across 329 Part D plans, Fesoterodine averages $1.90/unit (NADAC). Lowest available: $0.824/unit. Highest in distribution: $9.26/unit.
Is Fesoterodine on the FDA shortage list?
No. Fesoterodine is not currently on the FDA Drug Shortage Database.
6 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (16 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.